Menu

FDA Lists Bio-Rad’s CFX96 Dx Real-Time PCR System for IVD Testing

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its CFX96 Dx Real-Time PCR System has been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19.

Bio-Rad Laboratories
May 20, 2020

The FDA listing extends access to the instrument to assay developers and testing laboratories in the U.S.

Throughout the COVID-19 pandemic, the CFX96 Dx Real-Time PCR System has been used by laboratories outside the U.S. that require an IVD platform to detect SARS-CoV-2. The system has also met the CE mark requirements for IVD use in Europe and is registered with regulatory bodies for IVD use in many other countries.

"We are pleased our CFX96 Dx Real-Time PCR System is now available for COVID-19 testing in U.S. markets," said Annette Tumolo, Bio-Rad Executive Vice President, President, Life Science Group. "By identifying those who test positive for the virus, individuals can be quarantined and receive treatment more quickly, helping to contain the spread of this disease."

The CFX96 Dx Real-Time System joins other Bio-Rad products that are being used for the detection of COVID-19, including Bio-Rad's SARS-CoV-2 Droplet Digital PCR (ddPCR) Kit; Platelia SARS-CoV-2 Total Ab assay; and the SARS-CoV-2 Standard, which is used to support laboratory assay validation of COVID-19 testing.

BIO-RAD, DROPLET DIGITAL, and DDPCR are trademarks of Bio-Rad Laboratories, Inc., in certain jurisdictions.

September 2020

Human Paths

Archaeology and genetics are starting to resolve humanity’s origin and spread

Marketplace

Sponsored Product Updates

Western Blot Protein Detection: Enzymatic vs. Fluorescence Methods
Download this article to learn how to pick the best detection technique for your protein research!
Advanced Flow Cytometry Uncovers T Cell Biology
Download this white paper to understand T cell phenotype and function to improve therapeutics research!
Next-Generation Sequencing (NGS) Sample Preparation
Download this white paper to learn the best practices for optimizing sample homogenization in NGS nucleic acid extraction!
Bio-Rad Introduces StarBright Violet 515 Dyefor Flow Cytometry
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of StarBright Violet 515 (SBV515) Dye, the first of a new range of unique fluorescent nanoparticles, for use in flow cytometry.